Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 28: 805-812, 1982;
This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Comings, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Comings, D. E.

Clinical Chemistry, Vol 28, 805-812, Copyright © 1982 by American Association for Clinical Chemistry

Two-dimensional gel electrophoresis of human brain proteins. IV. Disorders of glial proliferation and a polymorphism of glial fibrillary acidic protein--GFAP Duarte

DE Comings

Several genetic and non-genetic neurological disorders are characterized by neuronal cell death, followed by astrocytic glial cell proliferation. Because the major intermediate filament in astrocytes is glial fibrillary acidic protein (GFAP), large amounts of this protein accumulate. The two-dimensional gel-electrophoretic pattern of gliosed tissue is described. It shows a massive accumulation of the 50 000- dalton GFAP charge isomers (8e:1--8) plus a series of breakdown products of lower molecular mass and more-acid charge. In addition, I describe a genetic polymorphism, GFAP-Duarte, presenting as an additional, basic charge isomer of GFAP. The possibility that this or other mutations of GFAP may predispose certain neurons to premature cell death is discussed.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the American Association for Clinical Chemistry.